Search
Search
Close this search box.

Wellness and beauty brand Kloris closes in on equity crowdfunding target

UK CBD business Kloris is closing in on its crowdfunding target.

The beauty and wellness brand is seeking to expand by attracting investors through the Seedrs fundraising platform.

Founded in 2018, Kloris’ products are already stocked in big high street retailers like Boots and Selfridges.

The company set itself a target of raising £250,000 via Seedrs and, at time of writing, is around £15,000 away with 22 days left until the investment deadline.

Kloris reported revenue growth of 172% in the last year and is valued at around £6.1m.

Co-founder Kim Smith said: “With over 90% funded at this stage of the campaign we are thrilled at the shared excitement and interest within this space.”

Kloris co-founder Kim Smith

The company becomes the latest in the CBD space to turn to Seedrs to try and attract investment.

Online marketplace Alphagreen and and CBD craft beer company Cannabrew are among companies which have already turned to the crowdfunding platform.

Founded in 2012, the London-based business allows companies to raise equity by selling a stake in the company through its digital market.

Smith previously commented on Seedrs: “Throughout this time we have had many inquiries about the opportunity to invest in us, as consumers become more educated about putting their money into businesses that match their ethics and interests.

“After such a positive year of growth and innovative product launches, now feels like the perfect time to invite our loyal customer base to be part of the ongoing KLORIS journey. We are thrilled to launch our first crowdfund with Seedrs.”

[activecampaign form=31]

⏰ Pre-order discount ends Jan 15
-- Days
-- Hours
-- Mins
Data packs delivered January 2026
🔬 New Report Due January 2026

Global Medical Cannabis Market Review 2026

A comprehensive analysis of the international medical cannabis supply chain — examining country-specific data on exports, imports, market size, domestic production, and distribution landscapes. Understand the driving forces behind global supply dynamics, the impact of telemedicine on patient access, and regulatory changes shaping the market.

What's covered

  • 📊 Global supply chain overview — understand export/import dynamics and domestic production capabilities
  • 🌍 8 export country snapshots — Canada, Portugal, Denmark, North Macedonia, Spain, Australia, Czech Republic, South Africa
  • 👥 6 patient market snapshots — Australia, Germany, UK, Poland, Brazil, France
  • 🔮 Key themes — Canada's global impact, telemedicine growth, new market openings, quota changes
Export Markets
🇨🇦 Canada 🇵🇹 Portugal 🇩🇰 Denmark 🇲🇰 N. Macedonia 🇪🇸 Spain 🇦🇺 Australia 🇨🇿 Czechia 🇿🇦 South Africa
Patient Markets
🇦🇺 Australia 🇩🇪 Germany 🇬🇧 UK 🇵🇱 Poland 🇧🇷 Brazil 🇫🇷 France
100% free • No credit card required
As trusted by
DIAGEO KPMG Coca-Cola BARCLAYS BNP PARIBAS AB InBev NOVARTIS Johnson & Johnson PEPSICO AXA POLITICO Bloomberg amazon CNN Business
Part of our annual market review series GDPR compliant

Related Posts

Related Posts

CONNECT

Related Posts

Related Posts

Recent Posts

Related Posts

Subscribe to our mailing list to receives daily updates!

We won’t spam you

Categories

Browse by Tags

CATEGORIES

EDITION

BUSINESS OF CANNABIS

© 2023 Prohibition Holdings Ltd. All Rights Reserved.

EDITION

Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?